These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
349 related articles for article (PubMed ID: 18798260)
21. miR-125a-5p Functions as Tumor Suppressor microRNA And Is a Marker of Locoregional Recurrence And Poor prognosis in Head And Neck Cancer. Vo DT; Karanam NK; Ding L; Saha D; Yordy JS; Giri U; Heymach JV; Story MD Neoplasia; 2019 Sep; 21(9):849-862. PubMed ID: 31325708 [TBL] [Abstract][Full Text] [Related]
22. Long noncoding RNA MEG3 decreases the growth of head and neck squamous cell carcinoma by regulating the expression of miR-421 and E-cadherin. Ji Y; Feng G; Hou Y; Yu Y; Wang R; Yuan H Cancer Med; 2020 Jun; 9(11):3954-3963. PubMed ID: 32277605 [TBL] [Abstract][Full Text] [Related]
23. A novel saliva-based microRNA biomarker panel to detect head and neck cancers. Salazar C; Nagadia R; Pandit P; Cooper-White J; Banerjee N; Dimitrova N; Coman WB; Punyadeera C Cell Oncol (Dordr); 2014 Oct; 37(5):331-8. PubMed ID: 25156495 [TBL] [Abstract][Full Text] [Related]
24. Circulating microRNAs as novel prognosis biomarkers for head and neck squamous cell carcinoma. Hou B; Ishinaga H; Midorikawa K; Shah SA; Nakamura S; Hiraku Y; Oikawa S; Murata M; Takeuchi K Cancer Biol Ther; 2015; 16(7):1042-6. PubMed ID: 25950115 [TBL] [Abstract][Full Text] [Related]
25. Tumor suppressive microRNA-218 inhibits cancer cell migration and invasion through targeting laminin-332 in head and neck squamous cell carcinoma. Kinoshita T; Hanazawa T; Nohata N; Kikkawa N; Enokida H; Yoshino H; Yamasaki T; Hidaka H; Nakagawa M; Okamoto Y; Seki N Oncotarget; 2012 Nov; 3(11):1386-400. PubMed ID: 23159910 [TBL] [Abstract][Full Text] [Related]
26. The microRNA miR-29c-5p inhibits cell proliferation and migration by targeting TMEM98 in head and neck carcinoma. Li J; Chen W; Luo L; Liao L; Deng X; Wang Y Aging (Albany NY); 2020 Nov; 13(1):769-781. PubMed ID: 33257597 [TBL] [Abstract][Full Text] [Related]
27. miR-21 increases the programmed cell death 4 gene-regulated cell proliferation in head and neck squamous carcinoma cell lines. Sun Z; Li S; Kaufmann AM; Albers AE Oncol Rep; 2014 Nov; 32(5):2283-9. PubMed ID: 25175929 [TBL] [Abstract][Full Text] [Related]
28. Synthetic Evaluation of MicroRNA-1-3p Expression in Head and Neck Squamous Cell Carcinoma Based on Microarray Chips and MicroRNA Sequencing. Chen Y; Liu M; Jin H; Peng B; Dai L; Wang S; Xing H; Wang B; Wu Z Biomed Res Int; 2021; 2021():6529255. PubMed ID: 34485523 [TBL] [Abstract][Full Text] [Related]
29. The role of HOXB9 and miR-196a in head and neck squamous cell carcinoma. Darda L; Hakami F; Morgan R; Murdoch C; Lambert DW; Hunter KD PLoS One; 2015; 10(4):e0122285. PubMed ID: 25860510 [TBL] [Abstract][Full Text] [Related]
30. EIF2C is overexpressed and amplified in head and neck squamous cell carcinoma. Chang SS; Smith I; Glazer C; Hennessey P; Califano JA ORL J Otorhinolaryngol Relat Spec; 2010; 72(6):337-43. PubMed ID: 20924207 [TBL] [Abstract][Full Text] [Related]
31. MicroRNA expression profiles of cancer stem cells in head and neck squamous cell carcinoma. Yata K; Beder LB; Tamagawa S; Hotomi M; Hirohashi Y; Grenman R; Yamanaka N Int J Oncol; 2015 Oct; 47(4):1249-56. PubMed ID: 26323893 [TBL] [Abstract][Full Text] [Related]
32. microRNA-203 suppresses invasion and epithelial-mesenchymal transition induction via targeting NUAK1 in head and neck cancer. Obayashi M; Yoshida M; Tsunematsu T; Ogawa I; Sasahira T; Kuniyasu H; Imoto I; Abiko Y; Xu D; Fukunaga S; Tahara H; Kudo Y; Nagao T; Takata T Oncotarget; 2016 Feb; 7(7):8223-39. PubMed ID: 26882562 [TBL] [Abstract][Full Text] [Related]
33. Integrated analysis of deregulation microRNA expression in head and neck squamous cell carcinoma. Qi CL; Sheng JF; Huang ML; Zou Y; Wang YP; Wang F; Zeng F; Hua QQ; Chen SM Medicine (Baltimore); 2021 Feb; 100(6):e24618. PubMed ID: 33578572 [TBL] [Abstract][Full Text] [Related]
34. Regulation of microRNA expression by hepatocyte growth factor in human head and neck squamous cell carcinoma. Susuki D; Kimura S; Naganuma S; Tsuchiyama K; Tanaka T; Kitamura N; Fujieda S; Itoh H Cancer Sci; 2011 Dec; 102(12):2164-71. PubMed ID: 21899661 [TBL] [Abstract][Full Text] [Related]
35. Tumour-suppressive microRNA-29s inhibit cancer cell migration and invasion by targeting laminin-integrin signalling in head and neck squamous cell carcinoma. Kinoshita T; Nohata N; Hanazawa T; Kikkawa N; Yamamoto N; Yoshino H; Itesako T; Enokida H; Nakagawa M; Okamoto Y; Seki N Br J Cancer; 2013 Nov; 109(10):2636-45. PubMed ID: 24091622 [TBL] [Abstract][Full Text] [Related]
36. Low-level expression of microRNAs let-7d and miR-205 are prognostic markers of head and neck squamous cell carcinoma. Childs G; Fazzari M; Kung G; Kawachi N; Brandwein-Gensler M; McLemore M; Chen Q; Burk RD; Smith RV; Prystowsky MB; Belbin TJ; Schlecht NF Am J Pathol; 2009 Mar; 174(3):736-45. PubMed ID: 19179615 [TBL] [Abstract][Full Text] [Related]
37. Loss of miR-125b-1 contributes to head and neck cancer development by dysregulating TACSTD2 and MAPK pathway. Nakanishi H; Taccioli C; Palatini J; Fernandez-Cymering C; Cui R; Kim T; Volinia S; Croce CM Oncogene; 2014 Feb; 33(6):702-12. PubMed ID: 23416980 [TBL] [Abstract][Full Text] [Related]